which has better results semaglutide or tirzepatide When it comes to versus for weight loss, the “best” choice is never one-size-fits-all. At a premium, medically guided level, we compare how each option supports appetite regulation, metabolic response Semaglutide vs Tirzepatide: Weight Loss,

Tips to Maximise Weight Loss on Mounjaro Stick to high-protein, low-carb meals

A patient already being treated should not be switched from one antipsychotic class to the other, as this may cause more fetal and maternal complications

In the USA, a 4-week supply of Ozempic costs approximately $1,029.99, while the same supply is available for $429.99 from DrugsByCanada.com

Mike Haney: So the clinical indication, as I understand it, for getting one of these drugs for the purpose of obesity is a BMI of 30, or a BMI of 27 with another condition like diabetes

Phase 2 and Phase 3 trial data Major clinical trials: Phase 2 (24-week trial, 2008): 203 obese participants Three dose groups: 0.25mg, 0.5mg, 1.0mg daily Placebo-controlled, randomized Primary outcome: Weight loss percentage Phase 2 results: Key findings: Dose-dependent weight loss 1mg dose: Average 23 lbs lost (starting weight ~220 lbs) Best responders: 15-20% weight loss Comparable to semaglutide 2.4mg But higher dropout due to side effects Phase 3 trials (planned but never completed): Intended for FDA approval Halted due to cardiovascular concerns Increased heart rate 5-10 bpm average Blood pressure elevation 2-5 mmHg Risk-benefit ratio questioned Development suspended 2010 Long-term data (limited): 1-year extension studies showed sustained loss Weight plateau at 6-9 months Some regain if discontinued No controlled trials beyond 1 year Safety concerns prevented longer studies Compare to semaglutide trials and tirzepatide results